Financhill
Back

Immunic Stock Predictions

Sell
40

IMUX
Immunic

Last Price:
1.26
Seasonality Move:
15.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Immunic Stock Forecast

  • Is Immunic Stock Undervalued?
    The current Immunic [IMUX] share price is $1.25. The Score for IMUX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • IMUX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Immunic Stock Go Up Next Year?

Data Unavailable

Immunic Stock Rating

Data Unavailable

Immunic Stock Price History

Is IMUX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMUX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
imux.com

52-Week Data

52-Week High:
3.11
52-Week Low:
0.95

Prediction Charts

Market Cap:
112.15M
Price in USD:
1.25
Volume:
1.41M
Beta:
2.45

Technical Analysis

SMA50:
1.30
SMA100:
1.30
SMA200:
1.34
52-Wk Change:
-31.22%

Stock Predictions

  • Is Immunic stock public?
    Yes, Immunic is a publicly traded company.
  • What is the Immunic stock quote today?
    The Immunic stock price is 1.25 USD today.
  • How to buy Immunic stock online?
    You can buy Immunic shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 1.23 1.27 1.30 1.23
May-1 1.29 1.28 1.34 1.26
May-2 1.32 1.33 1.34 1.26
May-3 1.35 1.37 1.39 1.33
May-6 1.37 1.36 1.38 1.33
May-7 1.33 1.38 1.44 1.32
May-8 1.34 1.27 1.39 1.27
May-9 1.30 1.24 1.35 1.23
May-10 1.24 1.27 1.28 1.22
May-13 1.27 1.26 1.29 1.24
May-14 1.24 1.28 1.32 1.24
May-15 1.32 1.30 1.32 1.27
May-16 1.30 1.25 1.30 1.23
May-17 1.23 1.25 1.26 1.18

Immunic Earnings

Data Unavailable

Immunic Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.05 per share, an increase this year of $1.16 per share, and an increase next year of $0.17 per share.

* Immunic stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.